GALLANT 5 Tesaglitazar Versus Metformin
NCT00214591
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
580
Enrollment
INDUSTRY
Sponsor class
Stopped
The development program has been terminated
Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG:
GALIDA
Sponsor
AstraZeneca